Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pengcheng He
Observed names:
He Pengcheng,
PENG-CHENG HE,
Peng-Cheng He
Institutions:
First Affiliated Hospital of Xi'an Jiaotong University,
First Hospital of Xi'an,
Xi'an Jiaotong University
Observed institutions:
First Affiliated Hospital of Xi'an Jiaotong University,
First Hospital of Xi'an,
Xi'an Jiaotong University
ORCID:
0009-0003-5292-239X
Observed ORCIDs:
0009-0003-5292-239X,
0000-0002-0764-2458
OpenAlex ID:
A5002691135
An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial)
2022
·
Huai-Yu Wang
, Sha Gong
, et al.
·
Blood Cancer Journal
·
52
PDF
Current Advances and Challenges in CAR-T Therapy for Hematological and Solid Tumors
2025
·
Gengtian Zhang
, Mengyao Bai
, et al.
·
ImmunoTargets and Therapy
·
29
PDF
Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort study
2025
·
Wei Yin
, Xiaoyu Yan
, et al.
·
The Lancet Haematology
·
19
Initial Results of the first-in-human Phase 1 study of IBI3003, a novel trispecific antibody targeting GPRC5D, BCMA and CD3, in patients with relapsed or refractory multiple myeloma
2025
·
Jing Li
, Zhenyu Li
, et al.
·
Blood
·
8
Tetra-arsenic tetra-sulfide induces cell cycle arrest and apoptosis in retinoic acid-resistant acute promyelocytic leukemia cells
2015
·
YUAN WANG
, PENG-CHENG HE
, et al.
·
Biomedical Reports
·
8
PDF
Talquetamab, a GPRC5D×CD3 bispecific antibody, in Chinese patients with relapsed/refractory multiple myeloma: efficacy and safety from the phase 1/2 MonumenTAL-1 study
2025
·
Gang An
, Jie Jin
, et al.
·
Haematologica
·
7
PDF
Construction of SET overexpression vector and its effects on the proliferation and apoptosis of 293T cells
2016
·
YUAN WANG
, PENG-CHENG HE
, et al.
·
Molecular Medicine Reports
·
7
PDF
Clinical Characteristics, Prognostic Risk Factors, and Primary Treatment for Elderly Patients with Primary Central Nervous System Lymphoma: A Seer Database-Based Research
2025
·
Mengyao Zhang
, Runyu Yang
, et al.
·
Blood and Lymphatic Cancer Targets and Therapy
·
3
PDF
Discovery of the Novel HLA ‐ DRB4 *01:03:01:21 Allele by Third‐Generation HLA ‐Targeted Sequencing Technology
2024
·
Zihang Li
, Guangbo Tang
, et al.
·
HLA
·
3
Granulocyte colony-stimulating factor plus venetoclax and azacitidine in newly diagnosed acute myeloid leukemia: a multicenter phase 2 trial
2025
·
Huaiyu Wang
, Xiaohui Wang
, et al.
·
Blood Cancer Journal
·
2
PDF
Prognostic Potential of Pulmonary Hypertension in Patients with Hematologic Malignancy
2023
·
Miaojing Li
, Manyun Tang
, et al.
·
Advances in Therapy
·
2
Efficacy and safety of mitoxantrone hydrochloride liposome/ thiotepa/ busulfan/fludarabine (MTBF) conditioning regimen for salvage allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory acute myeloid leukemia: A single - Arm prospective clinical trial
2026
·
Juan Ren
, Tongxin Zhang
, et al.
·
Cell Transplantation
·
1
Targeting RBPMS selectively eliminates FOXO1-mediated stem cell signatures in mouse models of acute myeloid leukemia
2026
·
Ping Liu
, Sulin Zhang
, et al.
·
Science Translational Medicine
·
1
[The Efficacy of Combination of Avatrombopag and rhIL-11 in Adult Patients of Acute Myeloid Leukemia with Cancer Treatment-Induced Thrombocytopenia].
2025
·
Min-Na Luo
, Hai-Tao Zhang
, et al.
·
PubMed
·
1
Toxoplasmosis in a case with multiple serous effusions and severe aplastic anemia
2024
·
Xiaoning Wang
, Hao Li
, et al.
·
BMC Infectious Diseases
·
1
PDF
Efficacy and Safety of Mitoxantrone Hydrochloride Liposome in Combination with Thiotepa-Busulfan-Fludarabine As an Intensive Conditioning Regimen Preceding Salvage Allogeneic Stem Cell Transplantation in Relapsed or Refractory Acute Myeloid Leukemia
2024
·
Xiaoning Wang
, Juan Ren
, et al.
·
Blood
·
1
PDF
Zanubrutinib Plus R-CHOP (ZR-CHOP) in Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients Who Were Positron Emission Tomography-Positive after Two Cycles of R-CHOP: A Single-Arm, Open-Label, Multicenter Prospective Study
2024
·
Jie Wang
, He Li
, et al.
·
Blood
·
1
Safety and efficacy of birelentinib, a novel LYN/BTK dual inhibitor, in relapsed/refractory diffuse large B-cell lymphoma: a phase 2 study (TAI-SHAN9)
2026
·
Yajun Li
, Wei Liu
, et al.
·
Blood Cancer Journal
PDF
Clinical features and management of GPRC5D-associated adverse events in novel GPRC5D × CD3 bispecific talquetamab-treated relapsed/refractory multiple myeloma patients: the MonumenTAL-1 China cohort experience
2026
·
Gang An
, Jie Jin
, et al.
·
Hematology
Allogeneic hematopoietic stem cell transplantation promotes aGVHD via IL-33/IL-5/Foxp3 axis
2026
·
Huachao Zhu
, Ying Zhang
, et al.
·
BMC Immunology
Erratum to “Dietary stearic acid aggravates acute graft-versus-host disease by promoting oxidative stress and pro-inflammatory macrophage polarization” [Int. Immunopharmacol. 186 (2026) 117124]
2026
·
Yue Du
, Hui Feng
, et al.
·
International Immunopharmacology
PDF
Dietary stearic acid aggravates acute graft-versus-host disease by promoting oxidative stress and pro-inflammatory macrophage polarization
2026
·
Yue Du
, Hui Feng
, et al.
·
International Immunopharmacology
Epigenetic profiling to identify aggressiveness markers in non-Hodgkin lymphoma via a targeted methylation-based multi-cancer early detection (MCED) blood test.
2026
·
Xiang-Yu Zhao
, Shuhua Yi
, et al.
·
Journal of Clinical Oncology
REVO-U: A next-generation, gene-editing–free universal CAR-T platform to enable ultra–high-yield manufacturing and identification of early clinical activity in relapsed/refractory DLBCL.
2026
·
Di Wu
, Sijie Zhao
, et al.
·
Journal of Clinical Oncology
Se-methylselenocysteine alleviates sepsis-associated inflammation by upregulating GPX4 to inhibit macrophage ferroptosis
2026
·
Hui Feng
, Runyu Yang
, et al.
·
International Immunopharmacology
Show more works
View as search
Works count:
36
Citation count:
146
H-index:
7
I10-index:
3
Year
Topic
Type